-
Calls Purchased on BioDelivery Sciences International (BDSI)
Thursday, March 31, 2011 - 3:36pm | 131Shares of BioDelivery Sciences International (NASDAQ: BDSI) are higher on the session by 6.62%, currently trading at $3.54. The stock has been moving largely lower over the past three months, but it is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls...
-
Auriga Adjusts Earnings Estimates On Thermo Fisher Scientific
Thursday, March 31, 2011 - 9:13am | 131According to Auriga, Thermo Fisher Scientific (NYSE: TMO) signed agreements to divest Athena Diagnostics and Lancaster Labs, completed a $2.2B senior note offering, redeemed all $329MM of its 3.25% convertible senior subordinated notes, and announced a new $750MM share repurchase plan during the...
-
ProtonMedia and PPD to Introduce New Virtual Clinical Trial Training Solution
Wednesday, March 30, 2011 - 9:34am | 49ProtonMedia and PPD, Inc. (Nasdaq: PPDI) today announced they have entered into an agreement to jointly develop a new virtual clinical trial training solution that will improve the cost effectiveness, speed and quality of clinical trial training for life sciences organizations.
-
Response Genetics, Inc. Reports Q4 EPS of $(0.07) vs. $(0.08)
Tuesday, March 29, 2011 - 8:36am | 124Response Genetics Inc. (Nasdaq: RGDX) today announced its consolidated financial results and business progress for the fourth quarter. Total revenue increased by 88 percent to $6.4 million for the fourth quarter ended December 31, 2010, compared to $3.4 million for the same period last year....
-
Critical Stock Alerts: Insider Trade for Cisco, Yahoo, Netflix, Gap, Illumina, & Priceline.com
Monday, March 28, 2011 - 9:31am | 412Due to recent insider trades properly filed with the SEC, Insiderslab.com today releases special stock alerts and investment research reports for following companies: Cisco, Yahoo, Netflix, Gap, Illumina, & Priceline.com. By reading the following investment research reports, you can learn...
-
Benzinga's Top Upgrades (NOK, ILMN, NVDA, T)
Monday, March 28, 2011 - 8:21am | 139Nokia Corporation (NYSE: NOK) was upgraded by Goldman from "neutral" to "buy." NOK's shares closed at $8.35 on Friday. Nokia's trailing-twelve-month revenue is $59.39 billion. Illumina Inc (NASDAQ: ILMN) was upgraded by Auriga from "hold" to "buy.” ILMN's shares closed at $65.45 on Friday....
-
UPDATE: Auriga Color On ILMN Upgrade
Monday, March 28, 2011 - 8:10am | 145Auriga, which upgraded shares of Illumina Inc. (NASDAQ: ILMN), is providing some color on the stock. “Post-earnings, Illumina shares drifted lower as worries about demand within Genome Wide Association Studies (GWAS), a convertible offering, and profit-taking all weighed,” Auriga writes. “...
-
Auriga Upgrades Illumina To Buy, $75 PT
Monday, March 28, 2011 - 7:23am | 25Auriga USA has upgraded Illumina Inc. (NASDAQ: ILMN) from Neutral to Buy and reiterates its $75 price target.
-
Jefferies Maintains Hold on PerkinElmer (PKI)
Friday, March 25, 2011 - 8:35am | 94Jefferies is out with its report today on PerkinElmer (NYSE: PKI), maintaining Hold, and its $26 PT. In a note to clients, Jefferies writes, "PKI will acquire CambridgeSoft and ArtusLabs, designers of laboratory software and systems management solutions, for $220M, or ~3.4 times anticipated...
-
Goldman Sachs Neutral On Bruker corp. (BRKR)
Friday, March 25, 2011 - 7:58am | 227Goldman Sachs has a Neutral rating and a $18 price target on shares of Bruker corp. (NASDAQ: BRKR). In a note to clients, Goldman writes, "We hosted meetings with BRKR management yesterday that provided additional detail on (1) growth in a post-stimulus world, (2) impact from Japan, (3) and the...
-
PPD Announces the Nomination of Vaughn D. Bryson, Robert A. Ingram and Ralph Snyderman to its Board
Thursday, March 24, 2011 - 4:37pm | 83PPD, Inc. (Nasdaq: PPDI) today announced that it is nominating three new members for the stockholders to consider electing to its board of directors, Vaughn D. Bryson, Robert A. Ingram and Ralph Snyderman, M.D. They will join current directors Fred N. Eshelman, Pharm. D., executive chairman;...
-
SeraCare Introduces New Worldwide HIV Performance Panel
Thursday, March 24, 2011 - 8:11am | 92SeraCare Life Sciences (Nasdaq: SRLS) announces the launch of its new Worldwide HIV Performance Panel. This new HIV panel presents a group of HIV positive plasma samples with diverse variants of HIV, allowing efficient evaluation of HIV assays against multiple strains of the virus. SeraCare's...
-
PerkinElmer Signs Agreement to Acquire CambridgeSoft Corporation
Thursday, March 24, 2011 - 8:00am | 33PerkinElmer, Inc. (NYSE: PKI) today announced that it has signed a definitive agreement to acquire CambridgeSoft Corporation, and has completed the purchase of ArtusLabs, Inc.
-
Gabelli & Company Initiates Waters Corporation at Buy (WAT)
Tuesday, March 22, 2011 - 10:06am | 82Gabelli & Company is out with its report on Waters Corporation (NYSE: WAT), initiating WAT at Buy. In a note to clients, Gabelli writes, "We estimate that Water will earn $4.55 per share in 2011 and generate about $570 million of EBITDA on $1.3 billion of revenues. We are initiating coverage...
-
Nektar Initiates Phase 1 Clinical Study Evaluating NKTR-181
Monday, March 21, 2011 - 8:33am | 122Nektar Therapeutics (Nasdaq: NKTR) today announced that the first subjects were dosed in a new Phase 1 clinical study to evaluate NKTR-181, the company's next-generation opioid analgesic candidate. NKTR-181 is being developed to effectively treat pain while addressing the abuse liability and...